Learn About Spastic Paraplegia Type 5A

What is the definition of Spastic Paraplegia Type 5A?

Spastic paraplegia type 5A is one of a group of genetic disorders known as hereditary spastic paraplegias. These disorders are characterized by muscle stiffness (spasticity) and severe weakness in the lower limbs (paraplegia). Hereditary spastic paraplegias are often divided into two types: pure and complex. The pure types involve spasticity and weakness only in the lower limbs, while the complex types involve additional problems with other areas of the body; additional features can include changes in vision, changes in intellectual functioning, brain abnormalities, and disturbances in nerve function (neuropathy). Spastic paraplegia type 5A is usually a pure hereditary spastic paraplegia, although complex type features have been reported in some individuals, usually in those who have had the condition for many years.

Save information for later
Sign Up
What are the causes of Spastic Paraplegia Type 5A?

Spastic paraplegia type 5A is caused by mutations in the CYP7B1 gene. This gene provides instructions for making an enzyme called oxysterol 7-alpha-hydroxylase. In the brain, oxysterol 7-alpha-hydroxylase is involved in a pathway that converts cholesterol to hormones called neurosteroids. These neurosteroids increase nerve cell activity (excitability) and promote cell survival and communication between nerve cells. Oxysterol 7-alpha-hydroxylase helps maintain normal cholesterol levels in the brain and, by producing neurosteroids through altering existing hormones within the pathway, regulates the effects of neurosteroids on the brain.

How prevalent is Spastic Paraplegia Type 5A?

Spastic paraplegia type 5A is a rare condition. Its prevalence is unknown.

Is Spastic Paraplegia Type 5A an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Spastic Paraplegia Type 5A Local Doctors?
Learn about our expert tiers
Learn more
What are the latest Spastic Paraplegia Type 5A Clinical Trials?
PCSK9 Inhibitor Treatment for Patients With Hereditary Spastic Paraplegia Type 5

Summary: Spastic paraplegia type 5 (SPG5) is a rare subtype of hereditary spastic paraplegia, a highly heterogeneous group of neurodegenerative disorders defined by progressive neurodegeneration of the corticospinal tract motor neurons. SPG5 is caused by recessive mutations in the gene CYP7B1 encoding oxysterol-7a-hydroxylase. This enzyme is involved in the degradation of cholesterol into primary bile acid...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Imaging Biomarkers in Spastic Paraplegia Type 5

Summary: This is a research study aiming to identify imaging biomarkers in patients diagnosed with spastic paraplegia type 5 (SPG5)

Who are the sources who wrote this article ?

Published Date: September 01, 2017Published By: National Institutes of Health

What are the Latest Advances for Spastic Paraplegia Type 5A?